Longevity Fund 2 LP 3
3 · Decibel Therapeutics, Inc. · Filed Feb 11, 2021
Insider Transaction Report
Form 3
Longevity Fund 2 LP
10% Owner
Holdings
Convertible Series C Preferred Stock
→ Common Stock (79,143 underlying)
Footnotes (1)
- [F1]The Convertible Series C Preferred Stock is convertible into the issuer's common stock on a 12.6352-for-1 basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.